dear
editor
recent
publish
articl
highlight
special
concern
manag
patient
diabet
time
pandem
concern
use
angiotensin
convert
enzym
ace
inhibitor
angiotensin
receptor
blocker
arb
clarifi
public
ii
summaris
current
evid
regard
tri
arriv
reason
conclus
absenc
vaccin
antivir
drug
infect
sever
therapeut
approach
studi
one
approach
use
inhibitor
renin
angiotensin
system
name
ace
inhibitor
arb
hand
concern
rais
fact
patient
agent
might
increas
risk
infect
sever
acut
respiratori
syndrom
sar
angiotensin
convert
receptor
sar
well
coronavirus
express
type
alveolar
epitheli
cell
endothelium
sglycoprotein
surfac
coronaviru
bind
lead
conform
chang
sglycoprotein
allow
proteolyt
digest
host
cell
proteas
ultim
lead
intern
virion
iii
viral
sglycoprotein
inhibit
potenti
target
therapi
possibl
vaccin
develop
essenti
coronaviru
infect
blockad
thought
benefici
preventingtr
infect
retrospect
analysi
found
reduc
rate
death
endotrach
intub
patient
viral
pneumonia
continu
ace
inhibitor
iv
mice
coronaviru
induc
lung
injuri
show
improv
treat
losartan
v
far
infect
concern
data
ra
activ
effect
blockad
limit
present
hypokalaemia
could
marker
ra
activ
high
incid
hypokalaemia
report
patient
infect
vi
despit
small
studi
suggest
benefit
drug
act
ra
data
albeit
scarc
anim
model
human
studi
treatment
ace
inhibitor
arb
could
caus
regul
vii
ibuprofen
thiazolidinedion
also
shown
viii
ix
increas
express
could
theoret
increas
risk
infect
sar
could
concern
peopl
diabet
alreadi
elev
risk
infect
mani
factor
howev
current
evid
support
hypothesi
view
lack
robust
evid
either
benefit
harm
reason
patient
continu
use
ace
inhibitor
arb
recommend
european
societi
cardiolog
council
hypertens
european
societi
hypertens
x
xi
forti
cdoc
hospit
diabet
alli
scienc
chirag
enclav
new
delhi
india
correspond
gmailcom
